Drug delivery

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Drug delivery.php on line 2
Drug delivery

LE WE PMID CA

Drug delivery

3225

Drug Delivery

Antibodies (Immunochemistry)

Antineoplastic agents (Organometallic)

Antioxidants

Cell secretion (Intracellular protein transport)

CNS (Blood brain barrier)

Convection enhanced delivery

Differential Scanning Calorimetry

Drug delivery

Epilepsy (BASKET)

Imaging (Molecular)

Liposomes

Microneedles

Nanomedicine

Natural products

PEPT1

PepT2

Redox (BASKET)

Sonopheresis

Stem cell (BASKET)

Storage diseases

Transporter (Peptides)

2006 1	Protein transduction technology: a novel therapeutic perspective. [16508684] Acta Med Okayama 60(1): 1-11 (2006)
2010 2	Macromolecular drug transport into the brain using targeted therapy. [20015155] J Neurochem 113(1): 1-13 (2010)
1991 3	Utilizing vascular prostheses for drug delivery. [2027228] J Vasc Surg 13(5): 753-5 (1991)
2008 4	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. [18560012] Pharmacol Rev 60(2): 196-209 (2008)
2002 5	Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. [12429868] Pharmacol Rev 54(4): 561-87 (2002)
2009 6	The use of sonophoresis in the administration of drugs throughout the skin. [19470295] J Pharm Pharm Sci 12(1): 88-115 (2009)
2003 7	Drug delivery to the central nervous system: a review. [12935438] J Pharm Pharm Sci 6(2): 252-73 (2003)
2010 8	Recent advances in transdermal drug delivery. [20361297] Arch Pharm Res 33(3): 339-51 (2010)
2002 9	Recent progress in drug delivery systems for anticancer agents. [12135091] Arch Pharm Res 25(3): 229-39 (2002)
2005 10	Development of cell-specific targeting systems for drugs and genes. [15684468] Biol Pharm Bull 28(2): 195-200 (2005)
2007 11	Physical mechanisms and methods employed in drug delivery to tumors. [17878107] Acta Pharm 57(3): 249-68 (2007)
2008 12	Tumor targeting using liposomal antineoplastic drugs. [18488413] Int J Nanomedicine 3(1): 21-9 (2008)
2008 13	Recent advances in ceramic implants as drug delivery systems for biomedical applications. [19337409] Int J Nanomedicine 3(4): 403-14 (2008)
2007 14	Perspectives on transdermal ultrasound mediated drug delivery. [18203426] Int J Nanomedicine 2(4): 585-94 (2007)
2009 15	Intranasal drug delivery: how, why and what for? [20067706] J Pharm Pharm Sci 12(3): 288-311 (2009)
2005 16	Micellar solubilization of drugs. [16124926] J Pharm Pharm Sci 8(2): 147-65 (2005)
2003 17	Development of liposomal polyene antibiotics: an historical perspective. [12753730] J Pharm Pharm Sci 6(1): 67-83 (2003)
1998 18	Drug uptake from the airways and lungs. [9513788] Indian J Physiol Pharmacol 42(1): 3-14 (1998)
2007 19	Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. [17154393] Cancer 109(2): 170-9 (2007)
2005 20	Liposomal, nanoparticle, and conjugated formulations of anticancer agents. [16322279] Clin Cancer Res 11(23): 8230-4 (2005)
2004 21	Targeting of radio-isotopes for cancer therapy. [14976424] Cancer Biol Ther 3(4): 361-70 (2004)
2010 22	Ocular drug delivery. [20437123] AAPS J 12(3): 348-60 (2010)
2006 23	CNS drug delivery: opioid peptides and the blood-brain barrier. [16584136] AAPS J 8(1): E76-88 (2006)
2007 24	Varying polymer architecture to deliver drugs. [17907764] AAPS J 9(2): E235-40 (2007)
2008 25	Topical ocular delivery of NSAIDs. [18437583] AAPS J 10(2): 229-41 (2008)
2009 26	Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. [19125334] AAPS J 11(1): 13-22 (2009)
2006 27	Issues related to targeted delivery of proteins and peptides. [17025264] AAPS J 8(3): E466-78 (2006)
2008 28	Percutaneous permeation enhancement by terpenes: mechanistic view. [18446512] AAPS J 10(1): 120-32 (2008)
2008 29	Prodrug approaches for CNS delivery. [18446509] AAPS J 10(1): 92-102 (2008)
2002 30	Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. [12645998] AAPS PharmSci 4(4): E26 (2002)
2010 31	Application of in situ polymerization for design and development of oral drug delivery systems. [21063816] AAPS PharmSciTech 11(4): 1603-11 (2010)
2010 32	Injectable lipid emulsions-advancements, opportunities and challenges. [20976577] AAPS PharmSciTech 11(4): 1526-40 (2010)
2005 33	Cyclodextrins in drug delivery: an updated review. [16353992] AAPS PharmSciTech 6(2): E329-57 (2005)
2005 34	Floating drug delivery systems: a review. [16353995] AAPS PharmSciTech 6(3): E372-90 (2005)
2005 35	Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. [16353989] AAPS PharmSciTech 6(2): E298-310 (2005)
2009 36	Organic-inorganic composites for bone drug delivery. [19842042] AAPS PharmSciTech 10(4): 1158-71 (2009)
2009 37	Dental mold: a novel formulation to treat common dental disorders. [19466555] AAPS PharmSciTech 10(2): 692-702 (2009)
2008 38	Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. [18473177] AAPS PharmSciTech 9(2): 628-34 (2008)
2008 39	Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. [18446481] AAPS PharmSciTech 9(1): 191-6 (2008)
2010 40	Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? [20438781] Adv Drug Deliv Rev 62(9-10): 898-903 (2010)
2010 41	Platelets as delivery systems for disease treatments. [20619307] Adv Drug Deliv Rev 62(12): 1196-203 (2010)
2009 42	Mathematical modeling of molecular diffusion through mucus. [19135488] Adv Drug Deliv Rev 61(2): 101-14 (2009)
2007 43	Endocytic mechanisms for targeted drug delivery. [17659804] Adv Drug Deliv Rev 59(8): 748-58 (2007)
2007 44	Delivery of drugs and macromolecules to mitochondria. [17659805] Adv Drug Deliv Rev 59(8): 729-38 (2007)
2007 45	Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. [17669543] Adv Drug Deliv Rev 59(8): 782-97 (2007)
2007 46	Biodegradable nanoparticles for cytosolic delivery of therapeutics. [17683826] Adv Drug Deliv Rev 59(8): 718-28 (2007)
2009 47	Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. [19133304] Adv Drug Deliv Rev 61(2): 158-71 (2009)
2008 48	The chemistry of irreversible capture. [18538444] Adv Drug Deliv Rev 60(12): 1383-8 (2008)
2008 49	The design of guanidinium-rich transporters and their internalization mechanisms. [18164781] Adv Drug Deliv Rev 60(4-5): 452-72 (2008)
2008 50	Ultrasound for drug and gene delivery to the brain. [18486271] Adv Drug Deliv Rev 60(10): 1209-17 (2008)
2008 51	Micelles and nanoparticles for ultrasonic drug and gene delivery. [18486269] Adv Drug Deliv Rev 60(10): 1137-52 (2008)
2008 52	Microbubbles in ultrasound-triggered drug and gene delivery. [18486268] Adv Drug Deliv Rev 60(10): 1153-66 (2008)
2008 53	Ultrasound mediated delivery of drugs and genes to solid tumors. [18474406] Adv Drug Deliv Rev 60(10): 1193-208 (2008)
2008 54	Porous silicon in drug delivery devices and materials. [18508154] Adv Drug Deliv Rev 60(11): 1266-77 (2008)
2010 55	Beyond oncology--application of HPMA copolymers in non-cancerous diseases. [19909776] Adv Drug Deliv Rev 62(2): 258-71 (2010)
2009 56	Self-assembling materials for therapeutic delivery. [19010748] Acta Biomater 5(3): 817-31 (2009)
2010 57	Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. [20479980] Mar Drugs 8(4): 1305-22 (2010)
2010 58	Chitin and chitosan as multipurpose natural polymers for groundwater arsenic removal and AS2O3 delivery in tumor therapy. [20559486] Mar Drugs 8(5): 1518-25 (2010)
2002 59	Pressurised metered-dose inhalers (MDIs) versus dry powder inhalers devices (DPIs) to rapid-acting inhaled b2-agonists for asthma in children. [12199971] Allergol Immunopathol (Madr) 30(4): 245-9 (2002)
2010 60	Targeted drug delivery in pancreatic cancer. [19853645] Biochim Biophys Acta 1805(1): 97-104 (2010)
2010 61	Cyclotides, a promising molecular scaffold for peptide-based therapeutics. [20564025] Biopolymers 94(5): 611-6 (2010)
2009 62	How do poly lactide-co-glycolide microspheres for prostaglandin E1 operate in ischemic tissue? Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. [19556701] Circ J 73(7): 1201-2 (2009)
2007 63	'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. [17325789] Chem Soc Rev 36(3): 507-31 (2007)
2011 64	Mitochondria-targeted antioxidants as therapies. [21356165] Discov Med 11(57): 106-14 (2011)
2008 65	Cell penetrating peptide inhibitors of nuclear factor-kappa B. [18668204] Cell Mol Life Sci 65(22): 3564-91 (2008)
2010 66	Targeting of drugs and nanoparticles to tumors. [20231381] J Cell Biol 188(6): 759-68 (2010)
2009 67	Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency. [20210709] Biochemistry (Mosc) 74(13): 1567-74 (2009)
2009 68	Novel technologies for antiangiogenic drug delivery in the brain. [19262168] Cell Adh Migr 3(2): 224-9 (2009)
2008 69	Concept and clinical evaluation of carrier-mediated anticancer agents. [18378535] Oncologist 13(3): 248-60 (2008)
2011 70	The use of convection-enhanced delivery with liposomal toxins in neurooncology. [22069714] Toxins (Basel) 3(4): 369-97 (2011)
2011 71	Imaging of convection enhanced delivery of toxins in humans. [22069706] Toxins (Basel) 3(3): 201-6 (2011)
2009 72	Nanotechnology for delivery of drugs to the brain for epilepsy. [19332327] Neurotherapeutics 6(2): 323-36 (2009)
2009 73	Convection-enhanced delivery in the treatment of epilepsy. [19332329] Neurotherapeutics 6(2): 344-51 (2009)
2004 74	Molecular mechanisms of pulmonary peptidomimetic drug and peptide transport. [14969997] Am J Respir Cell Mol Biol 30(3): 251-60 (2004)
2003 75	Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. [14616418] Br J Clin Pharmacol 56(6): 588-99 (2003)
2003 76	Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. [14616419] Br J Clin Pharmacol 56(6): 600-12 (2003)
2010 77	The benefits and challenges associated with the use of drug delivery systems in cancer therapy. [20417189] Biochem Pharmacol 80(5): 762-70 (2010)
2010 78	Microspheres in cancer therapy. [21131762] Indian J Cancer 47(4): 458-68 (2010)
2007 79	Clinical studies with oral lipid based formulations of poorly soluble compounds. [18472981] Ther Clin Risk Manag 3(4): 591-604 (2007)
2008 80	Transporter-mediated specific drug therapy during pregnancy. [18974606] Drug Metab Pharmacokinet 23(5): 305 (2008)
2010 81	Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. [20593303] Pharm Res 27(9): 1759-71 (2010)
2011 82	In vivo methods to study uptake of nanoparticles into the brain. [20924653] Pharm Res 28(3): 456-71 (2011)
2010 83	Drug delivery systems for intraperitoneal therapy. [20198409] Pharm Res 27(5): 735-8 (2010)
2011 84	Nanomedicine's promising therapy: magnetic drug targeting. [21542699] Expert Rev Med Devices 8(3): 291-4 (2011)
2011 85	Drug discovery by formulation design and innovative drug delivery systems (DDS). [21881300] Yakugaku Zasshi 131(9): 1271-87 (2011)
2008 86	Ophthalmic light sensitive nanocarrier systems. [18275910] Drug Discov Today 13(3-4): 124-34 (2008)
2010 87	Chitosan nanoparticles: a promising system in novel drug delivery. [21048331] Chem Pharm Bull (Tokyo) 58(11): 1423-30 (2010)
2010 88	Drug delivery by red blood cells: vascular carriers designed by mother nature. [20192900] Expert Opin Drug Deliv 7(4): 403-27 (2010)
2010 89	Two-photon polymerization of microneedles for transdermal drug delivery. [20205601] Expert Opin Drug Deliv 7(4): 513-33 (2010)
2010 90	Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. [20331353] Expert Opin Drug Deliv 7(4): 429-44 (2010)
2008 91	Polymeric carriers: role of geometry in drug delivery. [19040392] Expert Opin Drug Deliv 5(12): 1283-300 (2008)
2009 92	Targeting anti-HIV drugs to the CNS. [19566446] Expert Opin Drug Deliv 6(8): 771-84 (2009)
2011 93	A survey and analysis of the role of molecular chaperone proteins and imidazole-containing dipeptide-based compounds as molecular escorts into the skin during stress, injury, water structuring and other types of cutaneous pathophysiology. [20546050] Int J Cosmet Sci 33(1): 1-16 (2011)
2008 94	Multi-functional nanocarriers to overcome tumor drug resistance. [18538481] Cancer Treat Rev 34(7): 592-602 (2008)
2008 95	Protein and Peptide drug delivery: oral approaches. [20046732] Indian J Pharm Sci 70(3): 269-77 (2008)
2009 96	Solid lipid nanoparticles: a modern formulation approach in drug delivery system. [20502539] Indian J Pharm Sci 71(4): 349-58 (2009)
2010 97	Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. [20055529] BioDrugs 24(1): 9-21 (2010)
2010 98	Targeting antioxidant and antithrombotic biotherapeutics to endothelium. [20490983] Semin Thromb Hemost 36(3): 332-42 (2010)
2009 99	Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. [18976706] Eur J Pharm Biopharm 71(3): 519-28 (2009)
2009 100	Engineered polymers for advanced drug delivery. [18977434] Eur J Pharm Biopharm 71(3): 420-30 (2009)
2009 101	Polymersome carriers: from self-assembly to siRNA and protein therapeutics. [18977437] Eur J Pharm Biopharm 71(3): 463-74 (2009)
2009 102	Delivery of small-interfering RNA (siRNA) to the brain. [19441914] Expert Opin Ther Pat 19(2): 137-40 (2009)
2008 103	Leuko-polymersomes. [19048993] Faraday Discuss 139(-): 129-41; discussion 213-28, 419-20 (2008)
2011 104	A review on composite liposomal technologies for specialized drug delivery. [21490759] J Drug Deliv 2011(-): 939851 (2011)
2010 105	Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. [20297904] Drug Deliv 17(4): 187-207 (2010)
2010 106	Bioresponsive matrices in drug delivery. [21114841] J Biol Eng 4(-): 15 (2010)
2009 107	Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells. [19785068] J BUON 14 Suppl 1(-): S33-42 (2009)
2010 108	New strategies for enzyme replacement therapy for lysosomal storage diseases. [20345279] Rejuvenation Res 13(2-3): 229-36 (2010)
2010 109	Delivery of therapeutic proteins. [20049941] J Pharm Sci 99(6): 2557-75 (2010)
2010 110	Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. [20980702] Invest Ophthalmol Vis Sci 51(11): 5403-20 (2010)
2008 111	Systemic treatment by inhalation of macromolecules--principles, problems, and examples. [19218633] J Physiol Pharmacol 59 Suppl 6(-): 53-79 (2008)
2007 112	Novel approaches to enhance pulmonary delivery of proteins and peptides. [18204175] J Physiol Pharmacol 58 Suppl 5(Pt 2): 615-25 (2007)
2009 113	Treatment of systemic diseases by inhalation of biomolecule aerosols. [20134033] J Physiol Pharmacol 60 Suppl 5(-): 15-26 (2009)
2007 114	Delivery of retinoid-based therapies to target tissues. [17378589] Biochemistry 46(15): 4449-58 (2007)
2010 115	Concise review: stem cells as an emerging platform for antibody therapy of cancer. [21089119] Stem Cells 28(11): 2084-7 (2010)
2011 116	Mucoadhesive drug delivery systems. [21430958] J Pharm Bioallied Sci 3(1): 89-100 (2011)
2011 117	Nucleic acid-lipid membrane interactions studied by DSC. [21430956] J Pharm Bioallied Sci 3(1): 70-6 (2011)
2009 118	Targeted delivery of therapeutics to endothelium. [18815813] Cell Tissue Res 335(1): 283-300 (2009)
2011 119	Application of supercritical antisolvent method in drug encapsulation: a review. [21796245] Int J Nanomedicine 6(-): 1429-42 (2011)
2007 120	Current molecular design of intelligent drugs and imaging probes targeting tumor-specific microenvironments. [18004453] Org Biomol Chem 5(23): 3745-57 (2007)
2010 121	Frontiers in cancer nanomedicine: directing mass transport through biological barriers. [20079548] Trends Biotechnol 28(4): 181-8 (2010)
2010 122	Exploring the cellular accumulation of metal complexes. [20104335] Dalton Trans 39(5): 1159-70 (2010)
2010 123	Nanodelivery in airway diseases: challenges and therapeutic applications. [19616124] Nanomedicine 6(2): 237-44 (2010)
2011 124	The application of carbon nanotubes in target drug delivery systems for cancer therapies. [21995320] Nanoscale Res Lett 6(-): 555 (2011)
2009 125	Polymer hydrogel capsules: en route toward synthetic cellular systems. [20644862] Nanoscale 1(1): 68-73 (2009)
2008 126	Transdermal drug delivery. [18997767] Nat Biotechnol 26(11): 1261-8 (2008)
2010 127	Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. [21028936] Mol Membr Biol 27(7): 247-59 (2010)
2010 128	Drug delivery to solid tumors by elastin-like polypeptides. [20546809] Adv Drug Deliv Rev 62(15): 1456-67 (2010)
2010 129	Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. [20478348] Adv Drug Deliv Rev 62(15): 1486-96 (2010)
2010 130	Silk-based delivery systems of bioactive molecules. [20298729] Adv Drug Deliv Rev 62(15): 1497-508 (2010)
2010 131	Drug structure-transport relationships. [21107662] J Pharmacokinet Pharmacodyn 37(6): 541-73 (2010)
2010 132	pH-Responsive nanoparticles for drug delivery. [20836539] Mol Pharm 7(6): 1913-20 (2010)
2010 133	Targeted delivery of RNAi therapeutics for cancer therapy. [21143026] Nanomedicine (Lond) 5(10): 1483-6 (2010)
2011 134	Cell-specific aptamer-mediated targeted drug delivery. [21182455] Oligonucleotides 21(1): 1-10 (2011)
2010 135	Hijacking solute carriers for proton-coupled drug transport. [21186281] Physiology (Bethesda) 25(6): 364-77 (2010)
2010 136	Targeted drug delivery across the blood-brain barrier using ultrasound technique. [21785679] Ther Deliv 1(6): 819-48 (2010)
2010 137	Intracellular delivery of RNA-based therapeutics using aptamers. [21643487] Ther Deliv 1(6): 849-61 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Drug delivery.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Drug delivery.php on line 92